This inventor holds 10 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Behringwerke Aktiengesellschaft, Previpharma Consulting Gmbh. Active years: 1976-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Marbach near Marburg an der Lahn, DE (1976)
- Marburg-Marbach, DE (1977)
- Marburg, Lahn, DE (1978)
- Marburg an der Lahn, DE (1984)
- Marburg, DE (1979 - 2023)
Company Filing History:
Years Active: 1976-2023
Title: Hermann Erich Karges: Innovator in Biopharmaceuticals
Introduction
Hermann Erich Karges is a prominent inventor based in Marburg, Germany, known for his significant contributions to the field of biopharmaceuticals. With ten patented innovations to his name, Karges has developed methods and processes that advance medical treatments, particularly in areas related to thromboembolic conditions.
Latest Patents
Among his recent patents, Karges has developed a method for isolating Glu-plasminogen from blood fractions. This invention includes using anion exchange chromatography on plasma sources, resulting in Glu-plasminogen that is beneficial for treating patients at risk of various disorders, including organ failure and thrombotic events.
Additionally, he holds a patent for a process that produces a virus-free concentrate of thrombin. This method utilizes soluble salts to create a purified preparation of thrombin, which is crucial for pharmaceutical applications, ensuring safety and efficacy in treatment options.
Career Highlights
Throughout his career, Karges has made a lasting impact in the biopharmaceutical sector, working with respected companies such as Behringwerke Aktiengesellschaft and Previpharma Consulting GmbH. His role in these companies showcases his dedication to developing safe and effective medical solutions.
Collaborations
Karges has collaborated with renowned professionals in the field, including Norbert Heimburger and Gerd Zettlmeissl. These partnerships have facilitated innovations that push the boundaries of medical treatments and research.
Conclusion
Hermann Erich Karges remains a vital figure in the realm of biopharmaceutical inventions. His patents not only demonstrate his innovative spirit but also his commitment to improving healthcare through advanced medical methodologies. As he continues to work in this essential field, his contributions are sure to benefit patients and practitioners alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile